Utama › Kanser Pankreas › Texas › San Antonio
Kajian klinikal Kanser Pankreas di San Antonio, TX
31 kajian untuk Kanser Pankreas sedang mencari peserta di lokasi dalam dan sekitar San Antonio (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Mengambil pesertaFasa 1/2
- Research Site, San Antonio
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Mengambil pesertaFasa 3
- Texas Oncology - San Antonio, San Antonio
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Mengambil pesertaFasa 1
- South Texas Accelerated Research Therapeutics (START), San Antonio
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology, San Antonio
A Study of PHN-012 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1
- PHN-012-001 Site, San Antonio
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Mengambil pesertaFasa 3
- Investigative Site US080, San Antonio
- Investigative Site US063, San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Mengambil pesertaFasa 1
- NEXT, San Antonio
- START - San Antonio, San Antonio
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
Mengambil pesertaKajian pemerhatian
- Children's Hospital of San Antonio, San Antonio
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology, San Antonio
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Mengambil pesertaFasa 2
- START- San Antonio, San Antonio
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Mengambil pesertaFasa 1
- South Texas Accelerated Research Therapeutics, San Antonio
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Mengambil pesertaFasa 1
- START San Antonio, San Antonio
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Mengambil pesertaFasa 3
- University of Texas Health Science Center at San Antonio, San Antonio
IDOV-Immune for Advanced Solid Tumors
Mengambil pesertaFasa 1
- South Texas Accelerated Research Therapeutics, San Antonio
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Mengambil pesertaFasa 1
- New Experimental Therapeutics of San Antonio LLC, San Antonio
- START - South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Mengambil pesertaFasa 1
- NEXT Oncology, San Antonio
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Mengambil pesertaFasa 1
- NEXT Oncology /ID# 243007, San Antonio
- South Texas Accelerated Research Therapeutics (START) /ID# 276268, San Antonio
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Mengambil pesertaFasa 1
- Research Site #2, San Antonio
- Research Site, San Antonio
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Mengambil pesertaFasa 1
- START, San Antonio
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Mengambil pesertaFasa 1/2
- NEXT Oncology, San Antonio
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Mengambil pesertaFasa 1/2
- Next Oncology, San Antonio
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT Oncology, San Antonio
A Study of MGC028 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- South Texas Accelerated Research Therapeutics (START) San Antonio, San Antonio
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Mengambil pesertaFasa 1/2
- NEXT Oncology, San Antonio
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Mengambil pesertaFasa 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
- UT Health San Antonio, San Antonio
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- START San Antonio, San Antonio
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Mengambil pesertaFasa 2
- Ohio State University-Telemedicine, San Antonio
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Mengambil pesertaFasa 1/2
- START San Antonio, San Antonio
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
Mengambil pesertaFasa 1/2
- Next Oncology, San Antonio, San Antonio
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- Exelixis Clinical Site #3, San Antonio
Kajian Kanser Pankreas di bandar lain
- Houston, TX61 kajian
- New York City, NY60 kajian
- Boston, MA43 kajian
- Nashville, TN39 kajian
- Los Angeles, CA35 kajian
- St. Louis, MO33 kajian
- Arlington, VA33 kajian
- Baltimore, MD31 kajian
- Philadelphia, PA26 kajian
- Tampa, FL26 kajian
- Durham, NC24 kajian
- San Diego, CA24 kajian
Kajian lain di San Antonio
- Kanser Paru-paru Bukan Sel Kecil59 kajian
- Kanser Payudara47 kajian
- Kanser Kolorektal46 kajian
- Kanser Metastatik44 kajian
- Kanser (semua jenis)41 kajian
- Obesiti40 kajian
- Diabetes Jenis 237 kajian
- Berat Badan Berlebihan34 kajian
- Kanser Ovari31 kajian
- Kanser Prostat28 kajian
- Kanser Endometrium27 kajian
- Kanser Paru-paru26 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.